Basket | Login


The AMYPAD consortium congratulates two young researchers on successfully defending their PhD thesis

Monday 06 September 2021

Two AMYPAD early career researchers successfully defended their PhD thesis in July 2021. On 1 July 2021, Lyduine Collij (Amsterdam UMC, Netherlands) successfully defended her PhD thesis entitled “The AMYPAD project: Towards the next stage in amyloid PET imaging”. This work was conducted in the context of the AMYPAD project and was the first AMYPAD PhD to be completed. In her thesis, Lyduine investigated the utility and potential of amyloid PET imaging in clinical and research settings within the field of Alzheimer’s disease.

Gemma Salvadó (BarcelonaBeta Brain Research Center, Spain) defended her thesis entitled “Detection of early cerebral amyloid-ß deposition by PET imaging and its downstream effects” on 9 July 2021. Her thesis focused on two main points relating to the study of the preclinical stage of Alzheimer’s disease. In the first instance, she focused on the early detection of amyloid-β, which is one of the first to accumulate in the brain in Alzheimer’s disease. In the second part of her thesis, Gemma investigated other possible mechanisms that are triggered in relation to this early amyloid-β accumulation.

The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA. This article reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.